3D Global Biotech Inc. (TPEX:6808)
Taiwan
· Delayed Price · Currency is TWD 53.20
+1.20 (2.31%)
May 13, 2025, 2:52 PM CST
3D Global Biotech Revenue
In the year 2024, 3D Global Biotech had annual revenue of 265.69M TWD with 1,187.68% growth. 3D Global Biotech had revenue of 222.02M in the half year ending December 31, 2024, with 2,951.84% growth.
Revenue
265.69M
Revenue Growth
+1,187.68%
P/S Ratio
15.59
Revenue / Employee
6.18M
Employees
43
Market Cap
4.14B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |